Search

Building regional regulatory capabilities in Asia and the Pacific requires strong oversight and sustained commitment to strengthening vaccine regulatory systems.

Investments must focus on diverse vaccine platforms, capacity building, and collaborative networks.

Feasibility assessments, demand forecasting, and direct public investments in manufacturing facilities support sustainable vaccine manufacturing.